Skip to the page

Data / Form D filings / AmplifyBio, LLC

AmplifyBio, LLC: Form D filings

AmplifyBio, LLC, a biotechnology company in West Jefferson, OH, filed 3 Form D notices with the SEC between 2021 and 2023. The latest, on November 15, 2023, reports $49.8 million sold of a $100 million offering to 4 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1425 PLAIN CITY-GEORGESVILLE ROAD, BLDG JM-10, West Jefferson, OH, 43162
Phone
(614) 424-5456
Industry
Biotechnology
Entity type
Limited Liability Company
Incorporated in
Delaware
Year incorporated
2021
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1864817

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Nov 15, 2023New notice$100,000,000$49,750,000$50,250,0004Oct 31, 2023sec.gov
Jun 29, 2022New notice$100,000,000$100,000,0008Apr 30, 2022sec.gov
May 27, 2021New notice$80,000,000$80,000,0003Apr 30, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Lewis Kelly Von ThaerDirector
Shaun Kelly RodriguezDirector
James Kelly GanjeiExecutive Officer
Rohan Kelly NirodyDirector
Matt Kelly VaughanDirector

Other biotechnology companies in Ohio that filed recently

Every Form D from the week of Nov 13, 2023 · All recent filings in Ohio · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what AmplifyBio, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.